A closed-loop approach to antiretroviral therapies for HIV infection

Biomedical Signal Processing and Control

Volumn 4, Issue 2, 2009, Pages 139-148

  Costanza, V ^a   Rivadeneira, P S ^c   Biafore, F L ^a,b   D'Attellis, C E ^a,b  

^a UNIVERSIDAD NACIONAL DE SAN MARTÍN   (Argentina)

^b FAVALORO UNIVERSITY   (Argentina)

^c UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

Author keywords

Antiretroviral drugs; Dynamic programming; HIV; Nonlinear dynamics; Optimal control

Indexed keywords

CONTROLLED DRUG DELIVERY; DRUG DOSAGE; DYNAMICS; INVERSE PROBLEMS; T-CELLS;

ANTIRETROVIRAL DRUGS; CHAOTIC BEHAVIORS; DOSE PRESCRIPTION; ENDEMIC EQUILIBRIUM; MEDICAL INTERVENTION; NUMERICAL TREATMENTS; OPTIMAL CONTROLS; SAFETY RECOMMENDATIONS;

DYNAMIC PROGRAMMING;

ANTIRETROVIRUS AGENT;

ANALYTIC METHOD; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROL SYSTEM; DATA ANALYSIS; DYNAMICS; ENDEMIC DISEASE; HEALTH CARE COST; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MEDICAL CARE; PATIENT ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; SIMULATION; VIRUS PARTICLE;

EID: 63449089707     PISSN: 17468094     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bspc.2009.02.005     Document Type: Article

References (29)

1. Alvarez-Ramirez J., Meraz M., and Velasco-Hernandez J.X. Feedback control of the chemotherapy of HIV. Int. J. Bifurcation Chaos 10 (2000) 2207-2219
2. Bangsberg D., Moss A., and Deek S. Paradoxes of adherence and drug resistance to HIV antiretroviral therapy. J. Antimicrob. Chemother. 53 (2004) 696-699
3. Barão M., and Lemos J.M. Nonlinear control of HIV-1 infection with a singular perturbation model. Biomed. Signal Process. Control 2 (2007) 248-257
4. Brandt M.E., and Chen G. Feedback control of a biodynamical model of HIV-1. IEEE Trans. Biomed. Eng. 48 (2001) 754-759
5. Bryson A.E., and Ho Y.-C. Applied Optimal Control (1975), Wiley, Washington, DC
6. Cahn P., Cassetti I., Wood R., Phanuphak P., Shiveley L., Bethell R.C., and Sawyer J. Efficacy and tolerability of 10-day monotherapy with apricitabine in antiretroviral-naive, HIV-1 infected patients. AIDS 20 9 (2006) 1261-1268
7. Camacho E.F., and Bordons C. Model Predictive Control. 2nd edition (2003), Springer-Verlag
8. Campello de Souza F.M. Modeling the dynamics of HIV-1 and CD4 and CD8 lymphocytes. IEEE Eng. Med. Biol. Mag. 18 (1999) 21-24
9. Caramelli B. Cardiovascular risk and metabolic effects in HIV patients. 29th World Congress of Internal Medicine, Buenos Aires. Argentina, September 16-20 (2008)
10. A. Cheruy, Méthodologie de la Modélisation, Les Cahiers d'EDORA (Reports INRIA-Sophia Antipolis, France) 866 (1988) 23-48.
11. Culshaw R.V., Ruan S., and Spiteri R.J. Optimal HIV treatment by maximizing immune response. J. Math. Biol. 48 (2004) 545-562
12. Davey Jr. R.T. HIV-1 and T-cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc. Natl. Acad. Sci. U.S.A. 98 26 (1999) 15109-15114
13. Ge S.S., Tian Z., and Lee T.H. Nonlinear control of a dynamic model of HIV-1. IEEE Trans. Biomed. Eng. 52 (2005) 353-361
14. HIV Treatment Options, October 2008, http://www.hivinfosource.org.
15. C. Hoffmann, B. Kamps, HIV Medicine 2007, Flying Publisher, October 2008, http://www.HIVmedicine.com.
16. Jeffrey A.M., Xia X., and Craig I.K. When to initiate HIV therapy: a control theoretic approach. IEEE Trans. Biomed. Eng. 50 11 (2003) 1213-1220
17. Kirschner D. Using mathematics to understand HIV immune dynamics. AMS Notices (1996) 191-202
18. Kirschner D., Lenhart S., and Serbin S. Optimal control of the chemotherapy of HIV. J. Math. Biol. 35 (1997) 775-792
19. Ko J.H., Kim W.H., and Chung C.C. Optimized structured treatment interruption for HIV therapy and its performance analysis on controllability. IEEE Trans. Biomed. Eng. 53 3 (2006) 380-386
20. Nowak M.A., and May R.M. Mathematical biology of HIV infections-antigenic variation and diversity threshold. Math. Biosci. 106 (1991) 1-21
21. Nowak M.A., and May R.M. AIDS pathogenesis-mathematical models of HIV and SIV infections. AIDS 7 (1993) 3-18
22. Nowak M.A., and May R.M. Virus Dynamics: Mathematical Principles of Immunology and Virology (2000), Oxford University Press, New York
23. D.A. Ouattara, C.H. Moog, Modeling of the HIV/AIDS infection: an aid for an early diagnosis of patients, in: I. Queinnec, et al. (Eds.), Biology and Control Theory: Current Challenges, LNCIS 357, Springer, 2007.
24. Perelson A.S., Kirschner D.E., and De Boer R. Dynamics of HIV infection of CD4+ T-cells. Math. Biosci. 114 (1993) 81-125
25. Perelson A.S., and Nelson P.W. Mathematical analysis of HIV-1 dynamics in vivo. SIAM Rev. 41 (1999) 3-44
26. Sontag E.D. Mathematical Control Theory. Deterministic Finite Dimensional Systems (1995), Springer, New York
27. Stafford M.A. Modeling plasma virus concentration during primary HIV infection. J. Theor. Biol. 203 (2000) 285-301
28. Treatment of HIV Infection, October 2008, http://www.niaid.nih.gov/factsheets/treat-hiv.htm.
29. U.S. Department of Health and Human Services, Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents, October 2008, http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.p.